To the best of our knowledge, we are reporting for the first time, a case control study on these four intronic FGFR2 variants taken together along with LD measurement, haplotype analysis and stratified analysis for possible correlation with patients' clinical parameters in susceptibility to breast cancer. This evidence concerns the gene FGFR2 and breast carcinoma.